This Immuneering Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday – Connect Biopharma Hldgs (NASDAQ:CNTB), Immuneering (NASDAQ:IMRX)

Oct 31, 2025
this-immuneering-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-friday-–-connect-biopharma-hldgs-(nasdaq:cntb),-immuneering-(nasdaq:imrx)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Clear Street analyst Bill Maughan initiated coverage on Korro Bio, Inc. (NASDAQ:KRRO) with a Buy rating and announced a price target of $93. Korro Bio shares closed at $36.45 on Thursday. See how other analysts view this stock.
  • Loop Capital analyst Brandon Rolle initiated coverage on THOR Industries, Inc. (NYSE:THO) with a Hold rating and announced a price target of $110. Thor Industries shares closed at $103.35 on Thursday. See how other analysts view this stock.
  • Mizuho analyst John Roberts initiated coverage on Solstice Advanced Materials, Inc. (NASDAQ:SOLS) with a Neutral rating and announced a price target of $54. Solstice Advanced Materials shares closed at $48.74 on Thursday. See how other analysts view this stock.
  • BTIG analyst Julian Harrison initiated coverage on Connect Biopharma Holdings Limited (NASDAQ:CNTB) with a Buy rating and announced a price target of $10. Connect Biopharma closed at $1.55 on Thursday. See how other analysts view this stock.
  • Leerink Partners analyst Andrew Berens initiated coverage on Immuneering Corporation (NASDAQ:IMRX) with an Outperform rating and announced a price target of $15. Immuneering shares closed at $6.41 on Thursday. See how other analysts view this stock.

Considering buying IMRX stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Leave a comment